Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection
- 28 January 2021
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 95 (4)
Abstract
HCV is a leading cause of liver disease, with an estimated 71 million people infected worldwide. During HCV infection, type I interferon (IFN) signaling displays potent antiviral and immunomodulatory effects.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (106-2320-B-039-042-, 107-2320-B-039-050-)
- Ministry of Science and Technology, Taiwan (106-2320-B-182-027-MY3, 109-2320-B-182-031-MY3)
- Chang Gung Medical Foundation (CMRPD1K0071-3, CMRPD1H0211-3, BMRP466)
- China Medical University, Taiwan (107-S-38, 108-MF-44)
This publication has 79 references indexed in Scilit:
- A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28–let-7 pathwayNature, 2013
- Molecular Basis for Interaction of let-7 MicroRNAs with Lin28Cell, 2011
- Immune Signaling by RIG-I-like ReceptorsImmunity, 2011
- IKK-dependent, NF-κB-independent control of autophagic gene expressionOncogene, 2010
- Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytesHepatology, 2010
- Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cellsNature Structural & Molecular Biology, 2009
- A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus ReplicationCell Host & Microbe, 2009
- Lin28 Mediates the Terminal Uridylation of let-7 Precursor MicroRNAMolecular Cell, 2008
- Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNANature, 2008
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005